ArticleBMC immunology2019

Treatment of established TH2 cells with 4μ8c, an inhibitor of IRE1α, blocks IL-5 but not IL-4 secretion.

Cody Poe et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.